http://www.unboundmedicine.com/medline/ebm/research/octreotideUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19303541/full_citation/[Irritable_bowel_syndrome:_dietary_and_pharmacological_therapeutic_options]Ducrotté P 
[Irritable bowel syndrome: dietary and pharmacological therapeutic options] [English Abstract, Journal Article]
Gastroenterol Clin Biol 2009 Feb.:S68-78.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19889861/full_citation/Growth_hormone_releasing_hormone__GHRH__activates_sleep_regualtory_neurons_of_the_rat_preoptic_hypothalamus_Peterfi Z, McGinty D, Sarai E, et al. 
Growth hormone releasing hormone (GHRH) activates sleep regualtory neurons of the rat preoptic hypothalamus. [JOURNAL ARTICLE]
Am J Physiol Regul Integr Comp Physiol 2009 Nov 4.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19888245/full_citation/Combination_of_endoscopic_band_ligation_with_terlipressin_is_better_than_that_with_octreotide_in_shortening_hospital_stayLo GH 
Combination of endoscopic band ligation with terlipressin is better than that with octreotide in shortening hospital stay? [Comment, Letter]
Am J Gastroenterol 2009 Nov; 104(11):2855; author reply 2855-6.
Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19887008/full_citation/Octreotide_treatment_of_patients_with_hepatocellular_carcinoma___a_retrospective_single_centre_controlled_study_Schoniger-Hekele M, Kettenbach J, Peck-Radosavljevic M, et al. 
Octreotide treatment of patients with hepatocellular carcinoma - a retrospective single centre controlled study. [JOURNAL ARTICLE]
J Exp Clin Cancer Res 2009 Nov 3; 28(1):142.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19886987/full_citation/Continuous_5_fluorouracil_infusion_plus_long_acting_Octreotide_in_advanced_well_differentiated_neuroendocrine_carcinomas__A_phase_II_trial_of_the_Piemonte_Oncology_Network_Brizzi MP, Berruti A, Ferrero A, et al. 
Continuous 5-fluorouracil infusion plus long acting Octreotide in advanced well differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte Oncology Network. [JOURNAL ARTICLE]
BMC Cancer 2009 Nov 3; 9(1):388.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19886965/full_citation/Beau's_lines_after_octreotide_therapy_Gregoriou S, Chiolou Z, Rigopoulos D 
Beau's lines after octreotide therapy. [JOURNAL ARTICLE]
Clin Exp Dermatol 2009 Nov 3.
Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19886356/full_citation/[Rectal_neuroendocrine_tumours]Louthan O 
[Rectal neuroendocrine tumours] [English Abstract, Journal Article]
Klin Onkol 2009; 22(5):195-201.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19885875/full_citation/Systematic_review_of_randomized_trials_on_vasoconstrictor_drugs_for_hepatorenal_syndrome_Gluud LL, Christensen K, Christensen E, et al. 
Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome. [JOURNAL ARTICLE]
Hepatology 2009 Sep 9.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19885812/full_citation/Long_term_survival_and_nearly_asymptomatic_course_of_carcinoid_tumour_with_multiple_metastases__treated_by_surgery_chemotherapy__90_Y_DOTATATE_and_LAR_octreotide_analogue_:_a_case_report_Kałużny M, Bolanowski M, Sukiennik-Kujawa M, et al. 
Long-term survival and nearly asymptomatic course of carcinoid tumour with multiple metastases (treated by surgery, chemotherapy, (90)Y-DOTATATE, and LAR octreotide analogue): a case report. [JOURNAL ARTICLE]
Endokrynol Pol 2009; 60(5):401-406.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19885591/full_citation/hSSTR2_expression_and_octreotide_treatment_reverses_multidrug_resistance_of_BxPC_3_human_pancreatic_cancer_cells_Sui C, Ma Q, Nan K, et al. 
hSSTR2 expression and octreotide treatment reverses multidrug resistance of BxPC-3 human pancreatic cancer cells. [JOURNAL ARTICLE]
Oncol Rep 2009 Dec; 22(6):1391-1396.
Abstract | Full Citation | Find Related Articles